Pinansya
Pinansya
Home500124 • BOM
Dr Reddy's Laboratories Ltd
₹1,200.80
Nob 4, 4:01:26 PM GMT+5:30 · INR · BOM · Disclaimer
StockSegurong nakalista sa INMay headquarter sa IN
Nakaraang pagsara
₹1,196.45
Sakop ng araw
₹1,193.20 - ₹1,204.00
Sakop ng taon
₹1,025.90 - ₹1,404.60
Market cap
998.63B INR
Average na Volume
240.70K
P/E ratio
17.34
Dividend yield
0.67%
Primary exchange
NSE
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
(INR)Set 2025Y/Y na pagbabago
Kita
88.05B9.84%
Gastos sa pagpapatakbo
31.90B7.31%
Net na kita
14.37B14.49%
Net profit margin
16.324.21%
Kita sa bawat share
17.8712.91%
EBITDA
21.29B-3.30%
Aktuwal na % ng binabayarang buwis
22.25%
Kabuuang asset
Kabuuang sagutin
(INR)Set 2025Y/Y na pagbabago
Cash at mga panandaliang investment
69.81B10.68%
Kabuuang asset
542.00B16.32%
Kabuuang sagutin
179.92B14.84%
Kabuuang equity
362.08B
Natitirang share
832.52M
Presyo para makapag-book
2.78
Return on assets
7.65%
Return on capital
9.87%
Net change in cash
(INR)Set 2025Y/Y na pagbabago
Net na kita
14.37B14.49%
Cash mula sa mga operasyon
15.57B67.16%
Cash mula sa pag-invest
-9.54B49.96%
Cash mula sa financing
-5.32B-132.96%
Net change in cash
902.00M-85.84%
Malayang cash flow
3.25B-17.00%
Tungkol
Dr. Reddy's Laboratories Ltd. is an Indian multinational pharmaceutical company based in Hyderabad, with U.S. headquarters in East Brunswick, New Jersey. The company was founded by Kallam Anji Reddy, who previously worked in the mentor institute Indian Drugs and Pharmaceuticals Limited. Dr. Reddy manufactures and markets a wide range of pharmaceuticals in India and overseas. The company produces over 190 medications, 60 active pharmaceutical ingredients for drug manufacture, diagnostic kits, critical care, and biotechnology. Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration. By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants – in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. By 2007, Dr. Wikipedia
Itinatag
1984
Mga Empleyado
27,811
Tumuklas pa
Maaaring interesado ka sa
Nabuo ang listahang ito mula sa mga paghahanap kamakailan lang, mga sinubaybayang security, at iba pang aktibidad. Alamin pa

“As is” na ibinibigay ang lahat ng data para lang sa mga layunin sa personal na impormasyon, at hindi inilaan na maging payong pinansyal, ni hindi rin ito para sa mga layunin sa trading o investment, buwis, legal, accounting, o iba pang payo. Hindi tagapayo sa investment ang Google, ni hindi rin ito pinansyal na tagapayo at walang inihahayag na pananaw, rekomendasyon, o opinyon patungkol sa anumang kumpanyang kasama sa listahang ito o sa anumang seguridad na inisyu ng mga kumpanyang iyon. Konsultahin ang iyong broker o pampinansyal na kinatawan para ma-verify ang presyo bago magsagawa ng anumang trade. Matuto pa
Naghanap din ang mga tao ng
Search
I-clear ang paghahanap
Isara ang paghahanap
Mga app ng Google
Pangunahing menu